BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 2783944)

  • 1. Responses of B cells from autoimmune mice to IL-5.
    Umland SP; Go NF; Cupp JE; Howard M
    J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 2 is a proliferative signal for B cells from autoimmune mice.
    Lehmann KR; Kotzin BL; Portanova JP; Santoro TJ
    Eur J Immunol; 1986 Sep; 16(9):1105-10. PubMed ID: 3093246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of Ly-1 B cells in autoimmune NZB and (NZB x NZW)F1 mice.
    Wofsy D; Chiang NY
    Eur J Immunol; 1987 Jun; 17(6):809-14. PubMed ID: 2954827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice.
    Wither JE; Roy V; Brennan LA
    Clin Immunol; 2000 Jan; 94(1):51-63. PubMed ID: 10607490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation.
    Kozono Y; Kotzin BL; Holers VM
    J Immunol; 1996 Jun; 156(11):4498-503. PubMed ID: 8666826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent changes in B lymphocyte lineage cell populations of autoimmune-prone BXSB mice.
    Jyonouchi H; Kincade PW; Good RA
    J Immunol; 1985 Feb; 134(2):858-64. PubMed ID: 2856930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice.
    Anderson CC; Cairns E; Rudofsky UH; Sinclair NR
    Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
    Klinman DM
    J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ
    J Immunol; 1987 Jun; 138(12):4106-13. PubMed ID: 2438334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective B cell tolerance induction in New Zealand black mice. I. Macrophage independence and comparison with other autoimmune strains.
    Goldings EA
    J Immunol; 1983 Dec; 131(6):2630-4. PubMed ID: 6196392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro and in vivo mitogenic and polyclonal antibody and autoantibody responses to peptidoglycan, LPS, protein A, PWM, PHA and Con A in normal and autoimmune mice.
    Dziarski R
    J Clin Lab Immunol; 1985 Feb; 16(2):93-109. PubMed ID: 3886911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased autoantibody production by NZB/NZW B cells in response to IL-5.
    Herron LR; Coffman RL; Bond MW; Kotzin BL
    J Immunol; 1988 Aug; 141(3):842-8. PubMed ID: 2969393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative responsiveness of B cells from autoimmune NZB mice to anti-immunoglobulin and interleukin-4.
    Hatakeyama M; Minato N; Kano S
    Clin Exp Immunol; 1989 Dec; 78(3):465-9. PubMed ID: 2612057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.